ARCHIVES

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

This article is from The Cancer Letter archive.

Vol. 32 No. 42 | November 22, 2006

Download PDF Visit The Full Archive

Related Articles

GAO Report On NCI Cancer Control Contracts (Continued)

August 1, 1980

News Analysis: Industry’s Accelerated Recovery Initiative May Push Manufacturers Toward Collusion

October 5, 2012

DCT Board Approves Recompetition Of Drug Development Contracts

June 25, 1993

Reversing Policy On Cancer Control Research, New Center Guidelines Top Accomplishments, Terry Believes

August 21, 1981

Regulatory Agencies: FDA Regulation Of Tobacco Signed by President Clinton

September 6, 1996

Mayo Clinic Study Finds Samarium May Expand Options For Osteosarcoma

February 22, 2002